Almansourah, Egypt

Saad Shaaban


Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Saad Shaaban

Introduction

Saad Shaaban is a prominent inventor based in Almansourah, Egypt. He has made significant contributions to the field of cancer treatment through his innovative research and development of organoselenium compounds. With a total of 16 patents to his name, Shaaban is recognized for his dedication to advancing medical science.

Latest Patents

Among his latest patents, Shaaban has developed an organoselenium compound for treating cancer. This method involves contacting cancer cells with a bis-(organoselanyl urea)aryl agent of Formula (I). The method demonstrates effective inhibition of cancer cell growth when using the bis-(organoselanyl urea)aryl agent of Formula (I) compared to doxorubicin. Additionally, he has patented a bis urea-based organoselenium compound and method for treating cancer, which includes administering a bis-(organoselanyl urea)aryl agent with Formula (I) to a subject with cancer. This method also shows effective inhibition of cancer cell growth compared to doxorubicin.

Career Highlights

Saad Shaaban is affiliated with Imam Mohammad Ibn Saud Islamic University, where he continues to contribute to research and innovation in the field of cancer treatment. His work is characterized by a commitment to improving therapeutic options for patients suffering from cancer.

Collaborations

Shaaban has collaborated with notable colleagues, including Tarek Ahmed Yousef and Ahmed A Al-Karmalawy. These partnerships have further enhanced his research efforts and contributed to the development of effective cancer treatments.

Conclusion

Saad Shaaban's innovative work in the field of cancer treatment through organoselenium compounds highlights his significant contributions to medical science. His ongoing research and collaboration with fellow scientists continue to pave the way for advancements in cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…